Scientific deep-dive

Low Testosterone and Weight Gain: Which Causes Which? Evidence Review

Excess weight lowers testosterone more reliably than low testosterone causes weight gain. The evidence on the two-way link, how much weight loss raises testosterone, whether TRT makes you gain weight, and which men should get tested.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
12 min read·16 citations

Both directions are real, but they are not equal. Excess body fat reliably lowers testosterone — men with obesity averaged 5.09 nmol/L (about 147 ng/dL) less total testosterone than men with a BMI under 25 [1] — and a genetic study suggests that arrow is causal [2]. Low testosterone can add fat too, but mostly when levels are pushed very low, and it shows up more as fat replacing muscle than as a jump on the scale [3][4]. The obesity-driven kind is reversible: diet-induced weight loss raised total testosterone by an average of 2.87 nmol/L (about 84 ng/dL) and bariatric surgery by 8.73 nmol/L (about 251 ng/dL) [5]. This article covers the two-way relationship; for testosterone replacement as a treatment, see Does TRT help with weight loss?

About this article

This review answers four questions: does excess weight lower testosterone, does low testosterone cause weight gain, how much does weight loss raise it, and does testosterone therapy move the scale? We relied mainly on meta-analyses, randomized trials, genetic (Mendelian randomization) studies, and the European Male Ageing Study, a large cohort followed over time. Testing advice follows Endocrine Society and European Academy of Andrology guidance; fluid and blood-count cautions come from the FDA prescribing information for testosterone.

The short answer

  • Excess weight lowers testosterone, and this is the stronger arrow. Heavier men show a turned-down brain signal to the testes [1], and genetic data estimate that going from a BMI of 30 to 25 would raise testosterone by about 13% [2].
  • Low testosterone can add fat, mostly when it is very low, and it changes body composition more than body weight [3][4].
  • Losing weight raises testosterone in proportion to how much you lose [5], and GLP-1 medications appear to follow the same rule [6].
  • Testosterone therapy usually trades fat for muscle, leaving average body weight unchanged in randomized trials [7].
  • Testing is for men with symptoms, not everyone who is overweight, and a low result needs a repeat fasting morning test to confirm it [8].

How excess weight lowers testosterone

The best population data come from the European Male Ageing Study (EMAS). Among 3,200 men aged 40 to 79, being overweight (BMI 25 to 30) was linked to 2.32 nmol/L (about 67 ng/dL) lower total testosterone, and obesity (BMI 30 or more) to 5.09 nmol/L (about 147 ng/dL) lower, compared with men whose BMI was under 25 [1]. The telling detail is LH, the pituitary hormone that tells the testes to make testosterone: in heavier men it was unchanged or lower. If the testes were failing, LH would climb to push them harder; instead, the signal from the hypothalamus and pituitary is dialed down.

Three mechanisms explain most of it [9]:

  • Aromatase. Fat tissue carries aromatase, the enzyme that converts testosterone into estradiol. More fat means more conversion: less testosterone, more estrogen.
  • Brain-level suppression. Higher estradiol, leptin, insulin, and inflammatory signals from enlarged fat tissue dampen GnRH, the hypothalamic hormone that drives LH, partly by disrupting kisspeptin signaling. The result is a “functional” hypogonadotropic hypogonadism: the machinery is intact but idling.
  • Lower SHBG. Obesity lowers sex hormone–binding globulin, the blood protein that carries much of the body’s testosterone, largely through liver fat and inflammation. Less SHBG pulls the total-testosterone number down and makes it a less reliable guide in heavier men [9], which is why the Endocrine Society calls for a free-testosterone measurement when SHBG may be altered [8].

The strongest test of cause is genetic. In a bi-directional Mendelian randomization study of 7,446 men from cohorts in Denmark, Germany, and Sweden, gene variants that raise BMI also lowered testosterone: each standard-deviation increase in genetically predicted BMI cut testosterone by 0.25 standard deviations. The authors estimated that bringing BMI from 30 down to 25 would raise testosterone by about 13% [2].

Can low testosterone cause weight gain?

Yes, but the clearest evidence comes from situations where testosterone is pushed far below normal. In a 16-week New England Journal of Medicine trial, 198 healthy men aged 20 to 50 had their own testosterone switched off with a drug (goserelin) and were randomized to placebo or one of four testosterone-gel doses. Body-fat percentage rose in the groups whose average testosterone ended up at 44, 191, and 337 ng/dL, and lean mass fell in the two lowest groups [3]. A parallel group of 202 men who also took an aromatase blocker revealed a twist: the gain in fat was driven mainly by the loss of estradiol, which men make from testosterone, while the loss of muscle and strength was driven by the loss of testosterone itself [3].

The real-world version is androgen deprivation therapy for prostate cancer. A meta-analysis of 16 studies found it raised percentage body fat by an average of 7.7% and lowered percentage lean mass by 2.8%, while body weight rose by just 2.1% [4]. Losing testosterone mainly changes what your weight is made of, not how much there is.

In the far more common situation — a man with obesity and moderately low testosterone — the evidence tilts the other way. The same genetic study that found BMI lowers testosterone found no effect of genetically lower testosterone on BMI, a result confirmed in a consortium of more than 104,000 people [2]. Clinicians still describe a self-reinforcing loop in which low testosterone favors fat gain, which lowers testosterone further [9]. The honest reading is that the fat-to-testosterone half of that loop is the better-proven one. For most men, low testosterone is more often a consequence of weight gain than its cause.

Functional vs organic hypogonadism: why the cause matters

Once low testosterone is confirmed, the Endocrine Society asks clinicians to find the cause [8]. A perspective in the Society’s journal, co-written by one of the guideline’s authors, lays out the two categories that matter for weight [10]:

Organic vs functional hypogonadism in men
Organic (classical)Functional
CauseStructural, destructive, or congenital disease of the testes, pituitary, or hypothalamus, such as a pituitary tumor or Klinefelter syndromeNo structural disease; the system is suppressed by excess fat, other illness, or drugs such as opioids or glucocorticoids
Typical pictureSevere deficiency, clinically and on blood tests; can appear at any ageMilder deficiency, often in middle-aged and older men with obesity or other illnesses
Reversible?Usually notPotentially, if the cause is treated
How commonLess common, and underdiagnosedMore common than organic hypogonadism
Usual first stepTestosterone replacement is usually warrantedLifestyle change and weight loss; testosterone considered alongside or after that

The European Academy of Andrology states the practical rule plainly: diagnose functional hypogonadism only when symptoms are backed by repeatedly low morning fasting testosterone and organic causes have been excluded, and make lifestyle change and weight reduction “the first approach in all overweight and obese men” [11]. The distinction cuts both ways. A young, otherwise healthy man with typical symptoms and unequivocally low testosterone should be evaluated for an organic cause [9] rather than told to diet, while a heavier man with borderline levels is usually best served by losing weight and rechecking.

Does losing weight raise testosterone? By how much

The largest synthesis is a systematic review and meta-analysis of 24 studies in men who lost weight through a low-calorie diet or bariatric surgery [5]. Both raised testosterone, bound and unbound. The average rise in total testosterone was 2.87 nmol/L (about 84 ng/dL) with diet and 8.73 nmol/L (about 251 ng/dL) after surgery; mean weight loss in those studies was about 10% with diet and 32% with surgery [9]. Estradiol fell and LH and FSH rose, the signature of the brake coming off. The best single predictor of how much testosterone rose was how much weight was lost, and gains were larger in younger men, men without diabetes, and men with more severe obesity [5].

Long-term data point the same way. Following 2,395 EMAS men for about 4.4 years, researchers found that weight loss went with a proportional rise, and weight gain with a proportional fall, in total testosterone and SHBG [12]. Free testosterone behaved differently: it changed significantly only in men who gained or lost at least 15% of their body weight. In practice, modest weight loss mainly lifts the total-testosterone number (with SHBG rising alongside it), while a large, sustained loss is what moves free testosterone.

Magnitude comparison

How much obesity lowers total testosterone, and how much different routes to weight loss raised it, in nmol/L. These figures come from different studies with different men and starting levels, so read them as rough magnitudes, not a head-to-head ranking.[1][5][9][13]

  • Overweight vs normal weight (BMI 25–30 vs under 25)2.32 nmol/L lower
    ≈67 ng/dL; EMAS, cross-sectional
  • Obesity vs normal weight (BMI 30+ vs under 25)5.09 nmol/L lower
    ≈147 ng/dL; EMAS, cross-sectional
  • Liraglutide, 16 weeks2.6 nmol/L rise
    ≈75 ng/dL; −7.9 kg, small randomized trial
  • Low-calorie diet2.87 nmol/L rise
    ≈83 ng/dL; about 10% weight loss, meta-analysis
  • Bariatric surgery8.73 nmol/L rise
    ≈252 ng/dL; about 32% weight loss, meta-analysis
How much obesity lowers total testosterone, and how much different routes to weight loss raised it, in nmol/L. These figures come from different studies with different men and starting levels, so read them as rough magnitudes, not a head-to-head ranking.

What about GLP-1 medications?

Because GLP-1 drugs produce large weight loss, the expected direction for a man with obesity is testosterone up, not down. A 2025 meta-analysis of seven studies (680 men with overweight or obesity) found that GLP-1 receptor agonists significantly raised total testosterone, with similar rises in free testosterone, SHBG, LH, and FSH; the more weight men lost, the larger the testosterone rise [6]. The authors were explicit that the data cannot show a direct effect of these drugs on the testes, so the benefit appears to run through weight loss. In a small randomized trial of 30 men with obesity-related functional hypogonadism, liraglutide raised total testosterone by 2.6 nmol/L and cut weight by 7.9 kg over 16 weeks [13]. For drug-specific detail, see does Ozempic lower testosterone? and the tirzepatide and testosterone review.

Does taking testosterone make you gain weight?

It can go either way, and on average the scale barely moves. A meta-analysis of 29 randomized trials in 1,083 middle-aged and older men found that testosterone reduced total body fat by 1.6 kg and increased fat-free mass by 1.6 kg, with no change in body weight [7]. A 2026 network meta-analysis of 23 trials in men with obesity-related functional hypogonadism found that testosterone therapy reduced waist circumference and increased lean mass [14]. So a man who starts testosterone may see his waist shrink while his weight holds steady, or even edges up as muscle is added. How longer-term registry data fit with this is covered in our TRT and weight loss review.

Two other effects can appear at the same time, and neither is fat:

  • Fluid retention. The prescribing information for injectable testosterone cypionate lists retention of sodium, chloride, and water among its adverse reactions, and warns that edema, with or without heart failure, “may be a serious complication in patients with pre-existing cardiac, renal or hepatic disease.” Ankle swelling is one of the symptoms patients are told to report [15].
  • Thicker blood. Testosterone raises hematocrit, the share of blood made up of red cells, an effect seen again in the 2026 network meta-analysis [14]. This is a safety issue, not a weight issue: the label calls for periodic hemoglobin and hematocrit checks to detect polycythemia [15], the Endocrine Society lists elevated hematocrit as a reason not to start [8], and European guidance treats a hematocrit above 48%–50% as a relative contraindication [11].

Why testosterone therapy is not a weight-loss drug

The Endocrine Society recommends testosterone to correct the symptoms of deficiency in men with confirmed hypogonadism. Weight loss is not among its indications; the guideline’s one weight-related recommendation runs the other way, suggesting short-term testosterone to help men with HIV, low testosterone, and weight loss regain body weight and lean mass. It also specifically recommends against using testosterone to improve blood-sugar control in men with type 2 diabetes and low testosterone [8]. In the liraglutide trial, testosterone gel produced the bigger testosterone rise (5.9 vs 2.6 nmol/L) but the smaller weight change (−0.9 vs −7.9 kg), and liraglutide raised LH and FSH, the body’s own drive to make testosterone, significantly more than the gel did [13].

That difference matters for younger men. The Endocrine Society recommends against testosterone therapy in men planning to father a child in the near term [8], whereas weight loss works by letting the body’s own hormone signals recover [5]. The network meta-analysis reached a cautious overall verdict: testosterone plus structured lifestyle therapy produced the largest rise in testosterone, but no single strategy was consistently best across outcomes, and confidence in many comparisons was low [14]. If you are weighing a GLP-1 and testosterone together, the trade-offs are covered in TRT plus GLP-1 stacking.

Who should get tested, and how

Weight alone is not a reason to test. The Endocrine Society recommends against routine screening of men in the general population and reserves the diagnosis for men with symptoms and signs of deficiency plus consistently low levels [8].

  • Symptoms that justify a test. In EMAS, the symptoms most tightly tied to low testosterone were sexual: fewer morning erections, low sexual desire, and erectile dysfunction. Fatigue, low mood, and trouble with vigorous activity were also related, but only the three sexual symptoms formed a consistent syndrome with low testosterone [16]. If erectile dysfunction is the main complaint, weight loss can help on its own terms; see can weight loss cure ED?
  • Two fasting morning tests. The guideline calls for a fasting morning total testosterone measured with an accurate assay, then a repeat fasting morning test to confirm [8]. The EMAS definition of late-onset hypogonadism paired at least three sexual symptoms with total testosterone below 11 nmol/L (about 320 ng/dL) and free testosterone below 220 pmol/L [16].
  • Free testosterone when weight is a factor. If total testosterone is near the lower limit, or SHBG may be altered, which obesity commonly does, free testosterone should be measured by equilibrium dialysis or estimated with an accurate formula [8][9].
  • LH and FSH to find the cause. These separate testicular from pituitary–hypothalamic causes and are part of telling organic from functional hypogonadism [8][10].

Where to start if your level is low

If you are carrying extra weight and your testosterone comes back borderline-low, the evidence points to the weight as the first lever: guidelines put weight reduction first for overweight and obese men [11], and the testosterone gain scales with the weight lost [5]. Useful questions for your clinician: Was my level measured fasting, in the morning, on two separate days? Should free testosterone be checked, given my weight? Do my LH and FSH suggest an organic cause that needs its own workup? And if I lose weight, when should we recheck? If testosterone is unequivocally low with significant symptoms, guidance allows testosterone to be considered alongside lifestyle changes rather than only after they fail, and an organic cause usually warrants replacement; those are conversations to have with your clinician [10]. Either way, judge testosterone therapy by whether it fixes your symptoms, not by what it does to the scale.

Frequently Asked Questions

It can, but mostly when testosterone is very low. Men whose testosterone was suppressed in a controlled trial, or lowered by prostate-cancer hormone therapy, gained body fat and lost lean mass while their weight rose only modestly. In the far more common case of a man with obesity and moderately low testosterone, a large genetic study suggests the excess weight is lowering the testosterone rather than the other way around.
In a meta-analysis of 24 studies (Corona 2013), diet-induced weight loss of about 10% raised total testosterone by an average of 2.87 nmol/L (roughly 83 ng/dL), and bariatric surgery, with about 32% weight loss, raised it by 8.73 nmol/L (roughly 252 ng/dL). The amount of weight lost was the best predictor of the rise. In long-term European data, free testosterone changed significantly only in men who lost at least 15% of their weight.
Usually it changes body composition more than weight. In a meta-analysis of 29 randomized trials (Isidori 2005), testosterone cut body fat by 1.6 kg and added 1.6 kg of fat-free mass, with no change in body weight. Some men retain fluid, which can add weight and, in men with heart, kidney, or liver disease, cause serious swelling. Testosterone also raises hematocrit, which needs regular monitoring.
Not just because of your weight. The Endocrine Society advises against routine screening; testing makes sense for men with symptoms, especially sexual ones such as low desire, fewer morning erections, or erectile dysfunction. Diagnosis needs two fasting morning total testosterone tests, plus free testosterone when obesity may have altered SHBG. If you are overweight with borderline results, weight loss is the recommended first step, followed by a recheck.

References

  1. 1.Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O’Neill TW, et al. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. J Clin Endocrinol Metab. 2008. PMID: 18270261.
  2. 2.Eriksson J, Haring R, Grarup N, Vandenput L, Wallaschofski H, Lorentzen E, et al. Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis. PLoS One. 2017. PMID: 28448539.
  3. 3.Finkelstein JS, Lee H, Burnett-Bowie SA, Pallais JC, Yu EW, Borges LF, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013. PMID: 24024838.
  4. 4.Haseen F, Murray LJ, Cardwell CR, O’Sullivan JM, Cantwell MM. The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis. J Cancer Surviv. 2010. PMID: 20091248.
  5. 5.Corona G, Rastrelli G, Monami M, Saad F, Luconi M, Lucchese M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013. PMID: 23482592.
  6. 6.Salvio G, Ciarloni A, Ambo N, Bordoni M, Perrone M, Rossi S, et al. Effects of glucagon-like peptide 1 receptor agonists on testicular dysfunction: A systematic review and meta-analysis. Andrology. 2025. PMID: 40105090.
  7. 7.Isidori AM, Giannetta E, Greco EA, Gianfrilli D, Bonifacio V, Isidori A, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005. PMID: 16117815.
  8. 8.Bhasin S, Brito JP, Cunningham GR, Hayes FJ, Hodis HN, Matsumoto AM, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018. PMID: 29562364.
  9. 9.Fernandez CJ, Chacko EC, Pappachan JM. Male Obesity-related Secondary Hypogonadism - Pathophysiology, Clinical Implications and Management. Eur Endocrinol. 2019. PMID: 31616498.
  10. 10.Grossmann M, Matsumoto AM. A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management. J Clin Endocrinol Metab. 2017. PMID: 28359097.
  11. 11.Corona G, Goulis DG, Huhtaniemi I, Zitzmann M, Toppari J, Forti G, et al. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology. Andrology. 2020. PMID: 32026626.
  12. 12.Camacho EM, Huhtaniemi IT, O’Neill TW, Finn JD, Pye SR, Lee DM, et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors: longitudinal results from the European Male Ageing Study. Eur J Endocrinol. 2013. PMID: 23425925.
  13. 13.Jensterle M, Podbregar A, Goricar K, Gregoric N, Janez A. Effects of liraglutide on obesity-associated functional hypogonadism in men. Endocr Connect. 2019. PMID: 30707677.
  14. 14.Yang L, He X, Wang S, Li T, Huang W, Feng Q. Treatment strategies for functional hypogonadism in obese men: a systematic review and network meta-analysis. J Sex Med. 2026. PMID: 42704281.
  15. 15.Pharmacia & Upjohn Company LLC. DEPO-TESTOSTERONE (testosterone cypionate) injection, solution — prescribing information. DailyMed, U.S. National Library of Medicine. 2026. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=cfbb53d4-b868-4a28-8436-f9112eb01c39
  16. 16.Wu FC, Tajar A, Beynon JM, Pye SR, Silman AJ, Finn JD, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010. PMID: 20554979.

Gonadorelin (GnRH): Fertility and Testosterone Evidence

Gonadorelin is synthetic GnRH with real evidence in GnRH deficiency: 93% testosterone normalization in a 76-patient trial and a 65.9% live-birth rate in a 25-year cohort. Its compounded use as a TRT-adjunct hCG alternative has no dedicated RCT.

14 min read

TRT + GLP-1 Stacking: The Evidence for Combining Testosterone and Semaglutide/Tirzepatide

Hypogonadal men who stack TRT with a GLP-1 see compounded benefits — TRT preserves lean mass during weight loss, GLP-1 drives fat loss. We review the TRAVERSE trial, the Saad 2016 testosterone+weight registry, drug interactions, and the clinical-stacking protocol.

12 min read

Does TRT Help With Weight Loss? Testosterone Therapy and Fat Loss Evidence

Testosterone replacement therapy (TRT) in hypogonadal men shifts body composition (fat down, lean mass up) but is not a weight-loss drug. Saad 2013, Ng Tang Fui 2016, T4DM 2021, TRAVERSE 2023 — verified evidence, risks, and TRT plus GLP-1 stacking.

14 min read

Best TRT Clinics 2026: Ranked Cash-Pay Testosterone Telehealth

We rank the best DTC TRT clinics for 2026 on diagnostic rigor, formulary breadth, monitoring, pricing, and state coverage. Hone, Marek, Maximus, Male Excel, Brightmeds, Feel30, Taurus Meds.

14 min read

How to Get Rid of Man Boobs: Chest Fat vs Gynecomastia, Evidence Review

Man boobs are either chest fat (pseudogynecomastia) or true gynecomastia, a growth of breast gland tissue. What causes each, how a clinician tells them apart, and what weight loss, chest exercise, tamoxifen, and surgery can realistically do.

11 min read

Does Ozempic Lower Testosterone? Male Fertility Evidence

Does Ozempic lower testosterone? In men with obesity, GLP-1 weight loss usually raises it. What the evidence says about semaglutide, testosterone, and sperm.

11 min read

Where to get GLP-1 safely: vetted online providers

Vetted telehealth providers that prescribe online. We compare pricing, form, and states served.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

8.1

RxSpan MD

Physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

8.0

Strut Health

Oral-lozenge compounded GLP-1 access

7.8

Yucca Health

Mainstream telehealth GLP-1 access